von Bueren, M., Armstrong, A. J., Szmulewitz, R., Petrylak, D., Villers, A., Azad, A., … Stenzl, A. (2019). Androgen deprivation therapy with enzalutamide or placebo in metastatic hormone-sensitive prostate cancer: ARCHES. In SWISS MEDICAL WEEKLY (Vol. 149, pp. 16S-16S). E M H SWISS MEDICAL PUBLISHERS LTD.

Bueren, Moritz von, Andrew J. Armstrong, Russell Szmulewitz, Daniel Petrylak, Arnauld Villers, Arun Azad, Antonio Alcaraz, et al. “Androgen deprivation therapy with enzalutamide or placebo in metastatic hormone-sensitive prostate cancer: ARCHES.” In SWISS MEDICAL WEEKLY, 149:16S-16S. E M H SWISS MEDICAL PUBLISHERS LTD, 2019.

von Bueren M, Armstrong AJ, Szmulewitz R, Petrylak D, Villers A, Azad A, et al. Androgen deprivation therapy with enzalutamide or placebo in metastatic hormone-sensitive prostate cancer: ARCHES. In: SWISS MEDICAL WEEKLY. E M H SWISS MEDICAL PUBLISHERS LTD; 2019. p. 16S-16S.

von Bueren, Moritz, et al. “Androgen deprivation therapy with enzalutamide or placebo in metastatic hormone-sensitive prostate cancer: ARCHES.” SWISS MEDICAL WEEKLY, vol. 149, E M H SWISS MEDICAL PUBLISHERS LTD, 2019, pp. 16S-16S.

von Bueren M, Armstrong AJ, Szmulewitz R, Petrylak D, Villers A, Azad A, Alcaraz A, Alekseev B, Iguchi T, Shore ND, Rosbrook B, Sugg J, Baron B, Chen L, Stenzl A. Androgen deprivation therapy with enzalutamide or placebo in metastatic hormone-sensitive prostate cancer: ARCHES. SWISS MEDICAL WEEKLY. E M H SWISS MEDICAL PUBLISHERS LTD; 2019. p. 16S-16S.